Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

Oncology
2
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

N
NeoGenomicsFORT MYERS, FL
1 program
1
AZD2936Phase 21 trial
Active Trials
NCT05414032Recruiting102Est. Jul 2028
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD2936Phase 2

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
NeoGenomicsAZD2936

Clinical Trials (1)

Total enrollment: 102 patients across 1 trials

NCT05414032NeoGenomicsAZD2936

Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC

Start: Jul 2023Est. completion: Jul 2028102 patients
Phase 2Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
1h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
1h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 102 patients
2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)